Delaying the oocyte maturation trigger by one day leads to a higher metaphase II oocyte yield in IVF/ICSI: A randomised controlled trial

Reproductive Biology and Endocrinology

Volumn 12, Issue 1, 2014, Pages

  Vandekerckhove, Frank ^a   Gerris, Jan ^a   Vansteelandt, Stijn ^b   De Baerdemaeker, An ^a   Tilleman, Kelly ^a   De Sutter, Petra ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; PROGESTERONE; RECOMBINANT FOLLITROPIN; FERTILITY PROMOTING AGENT;

ADULT; AGE; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; EMBRYO TRANSFER; ENDOMETRIOSIS; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTERMETHOD COMPARISON; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; METAPHASE II OOCYTE; MIDDLE AGED; OOCYTE MATURATION; OVARIAN RESERVE; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PATHOLOGY; PREGNANCY OUTCOME; PREGNANCY RATE; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; BELGIUM; BLOOD; DRUG ADMINISTRATION; DRUG EFFECTS; ECHOGRAPHY; EPIDEMIOLOGY; INFERTILITY, FEMALE; MALE; MALE INFERTILITY; METAPHASE; OOCYTE DEVELOPMENT; OVARY; OVULATION INDUCTION; PREGNANCY; SECRETION (PROCESS); SINGLE BLIND PROCEDURE; UNIVERSITY HOSPITAL;

ADULT; BELGIUM; CHORIONIC GONADOTROPIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; HOSPITALS, UNIVERSITY; HUMANS; INFERTILITY, FEMALE; INFERTILITY, MALE; MALE; METAPHASE; OOGENESIS; OVARY; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; PROGESTERONE; SINGLE-BLIND METHOD; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 84899916805     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-12-31     Document Type: Article

References (34)

1. Ectors FJ, Vanderzwalmen P, VanHoeck J, Nijs M, Verhaegen G, Delvigne A, Schoysman R, Leroy F. Relationship of human follicular diameter with oocyte fertilization and development after in-vitro fertilization or intracytoplasmic sperm injection. Hum Reprod 1997, 12:2002-2005. 10.1093/humrep/12.9.2002, 9363720.
2. Inaudi P, Germond M, Senn A, Degrandi P. Timing of Hcg administration in cycles stimulated for in-vitro fertilization - specific impact of heterogeneous follicle sizes and steroid concentrations in plasma and follicle fluid on decision procedures. Gynecol Endocrinol 1995, 9:201-208. 10.3109/09513599509160447, 8540289.
3. Kwan I, Bhattacharya S, McNeil A, Van Rumste MME. Monitoring of stimulated cycles in assisted reproduction IVF and ICSI. Cochrane Database Syst Rev 2008, [http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005289.pub2/abstract].
4. Kyrou D, Kolibianakis EM, Fatemi HM, Tarlatzis BC, Tournaye H, Devroey P. Is earlier administration of human chorionic gonadotrophin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotrophin-releasing hormone (GnRH) antagonists? A prospective randomized trial. Fertil Steril 2011, 96:1112-1115. 10.1016/j.fertnstert.2011.08.029, 21924414.
5. Garcia-Velasco JA, Isaza V, Vidal C, Landazabal A, Remohi J, Simon C, Pellicer A. Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix). Hum Reprod 2001, 16:2533-2539. 10.1093/humrep/16.12.2533, 11726570.
6. Bosch E, Labarta E, Crespo J, Simon C, Remohi J, Jenkins J, Pellicer A. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod 2010, 25:2092-2100. 10.1093/humrep/deq125, 20539042.
7. Dirckx K, Cabri P, Merien A, Galajdova L, Gerris J, Dhont M, De Sutter P. Does low-dose aspirin improve pregnancy rate in IVF/ICSI? A randomized double-blind placebo controlled trial. Hum Reprod 2009, 24:856-860.
8. Zegers-Hochschild F, Adamson GD, De Mouzon J, Ishihara O, Mansour R, Nygren K, Sullivan E, van der Poel S. International Committee for Monitoring Assisted Reproductive T, World Health O: The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009. Hum Reprod 2009, 24:2683-2687. 10.1093/humrep/dep343, 19801627.
9. Kolibianakis EM, Bourgain C, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles. Hum Reprod 2005, 20:2453-2456. 10.1093/humrep/dei069, 15890735.
10. Venetis CA, Kolibianakis EM, Papanikolaou E, Bontis J, Devroey P, Tarlatzis BC. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update 2007, 13:343-355. 10.1093/humupd/dmm007, 17405832.
11. Venetis CA, Kolibianakis EM, Bosdou JK, Tarlatzis BC. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. Hum Reprod Update 2013, 19:433-457. 10.1093/humupd/dmt014, 23827986.
12. Cetinkaya ES, Berker B, Aytac R, Atabekoglu C, Sonmezer M, Ozmen B. The value of the progesterone-to-estradiol ratio on the day of hCG administration in predicting ongoing pregnancy and live birth rates in normoresponders undergoing GnRH antagonist cycles. Eur J Obstet Gynecol Reprod Biol 2013, 170:452-457. 10.1016/j.ejogrb.2013.07.033, 23932375.
13. Kyrou D, Al-Azemi M, Papanikolaou EG, Donoso P, Tziomalos K, Devroey P, Fatemi HM. The relationship of premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist/recombinant FSH-stimulated cycles. Eur J Obstet Gynecol Reprod Biol 2012, 162:165-168. 10.1016/j.ejogrb.2012.02.025, 22425288.
14. Al-Azemi M, Kyrou D, Kolibianakis EM, Humaidan P, Van Vaerenbergh I, Devroey P, Fatemi HM. Elevated progesterone during ovarian stimulation for IVF. Reprod Biomed Online 2012, 24:381-388. 10.1016/j.rbmo.2012.01.010, 22377153.
15. Silverberg KM, Martin M, Olive DL, Burns WN, Schenken RS. Elevated serum progesterone levels on the day of human chorionic-gonadotrophin administration in in-vitro fertilization cycles do not adversely affect embryo quality. Fertil Steril 1994, 61:508-513.
16. Van Vaerenbergh I, Fatemi HM, Blockeel C, Van Lommel L, In't Veld P, Schuit F, Kolibianakis EM, Devroey P, Bourgain C. Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression. Reprod Biomed Online 2011, 22:263-271. 10.1016/j.rbmo.2010.11.002, 21273126.
17. Mio Y, Sekijima A, Iwabe T, Onohara Y, Harada T, Terakawa N. Subtle rise in serum progesterone during the follicular phase as a predictor of the outcome of invitro fertilization. Fertil Steril 1992, 58:159-166.
18. Bustillo M, Stern JJ, Coulam CB. Serum progesterone at the time of human chorionic gonadotrophin does not predict pregnancy in in-vitro fertilization and embryo transfer. Hum Reprod 1995, 10:2862-2867.
19. Fatemi HM, Blockeel C, Devroey P. Ovarian stimulation: today and tomorrow. Curr Pharm Biotechnol 2012, 13:392-397. 10.2174/138920112799362007, 21657998.
20. Murad NM. Ultrasound or ultrasound and hormonal determinations for in vitro fertilization monitoring. Int J Gynaecol Obstet 1998, 63:271-276. 10.1016/S0020-7292(98)00111-8, 9989897.
21. De Sutter P, Dhont M. Poor response after hormonal stimulation for in vitro fertilization is not related to ovarian aging. Fertil Steril 2003, 79:1294-1298. 10.1016/S0015-0282(03)00264-4, 12798873.
22. Elgindy EA. Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy. Fertil Steril 2011, 95:1639-1644. 10.1016/j.fertnstert.2010.12.065, 21324450.
23. Golan A, Herman A, Soffer Y, Bukovsky I, Ronel R. Ultrasonic control without hormone determination for ovulation induction in in-vitro fertilization-embryo transfer with gonadotrophin-releasing-hormone analog and human menopausal gonadotrophin. Hum Reprod 1994, 9:1631-1633.
24. Kovacs P, Kovats T, Bernard A, Zadori J, Szmatona G, Kaali SG. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotrophin during in vitro fertilization. Fertil Steril 2008, 90:2133-2137. 10.1016/j.fertnstert.2007.10.015, 18177866.
25. Lass A. Group UKToh: Monitoring of in vitro fertilization-embryo transfer cycles by ultrasound versus by ultrasound and hormonal levels: a prospective, multicenter, randomized study. Fertil Steril 2003, 80:80-85.
26. Miller KF, Goldberg JM, Falcone T. Follicle size and implantation of embryos from in vitro fertilization. Obstet Gynecol 1996, 88:583-586. 10.1016/0029-7844(96)00241-4, 8841223.
27. Mochtar MH, Custers IM, Koks CAM, Bernardus RE, Verhoeve HR, Mol BW, Van Wely M, van der Veen F. Timing oocyte collection in GnRH agonists down-regulated IVF and ICSI cycles: a randomized clinical trial. Hum Reprod 2011, 26:1091-1096. 10.1093/humrep/der048, 21362684.
28. Tan SL, Balen A, El Hussein E, Mills C, Campbell S, Yovich J, Jacobs HS. A prospective randomized study of the optimum timing of human chorionic gonadotrophin administration after pituitary desensitization in in vitro fertilization. Fertil Steril 1992, 57:1259-1264.
29. Hauzman EE, Bodri D, Guillen JJ, Vidal R, Coll O, Vernaeve V. Exploring different criteria by 2D or 3D ultrasound for triggering final oocyte maturation in an oocyte donation program: a randomized pilot study. Hum Reprod 2011, 26:I95-I96.
30. Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotrophin-releasing hormone antagonists. Fertil Steril 2004, 82:102-107.
31. Kolibianakis EM, Papanikolaou EG, Tournaye H, Camus M, Van Steirteghem AC, Devroey P. Triggering final oocyte maturation using different doses of human chorionic gonadotrophin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotrophin-releasing hormone antagonists and recombinant follicle-stimulating hormone. Fertil Steril 2007, 88:1382-1388. 10.1016/j.fertnstert.2006.12.058, 17445806.
32. Tarlatzis BC, Fauser BC, Kolibianakis EM, Diedrich K, Devroey P. GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update 2006, 12:333-340. 10.1093/humupd/dml001, 16567347.
33. Tremellen KP, Lane M. Avoidance of weekend oocyte retrievals during GnRH antagonist treatment by simple advancement or delay of hCG administration does not adversely affect IVF live birth outcomes. Hum Reprod 2010, 25:1219-1224. 10.1093/humrep/deq059, 20215127.
34. Stanger JD, Yovich JL. Follicle recruitment determines IVF productivity rate via the number of embryos frozen and subsequent transfers. Reprod Biomed Online 2013, 27:286-296. 10.1016/j.rbmo.2013.05.015, 23886680.